Aditya Chawla

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi request reprint Changing Clinician Practices and Attitudes Regarding the Use of Antiretroviral Therapy for HIV Treatment and Prevention: Results from the HPTN 065 Study
    Kate Buchacz
    Division of HIV AIDS Prevention, US Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Int Assoc Provid AIDS Care . 2016
  2. ncbi request reprint Changes in the clinical epidemiology of HIV infection in the United States: implications for the clinician
    Kate Buchacz
    Centers for Disease Control and Prevention, 1600 Clifton Road Northeast, Mailstop E 45, Atlanta, GA 30333, USA
    Curr Infect Dis Rep 11:75-83. 2009
  3. doi request reprint Trends in use of genotypic resistance testing and frequency of major drug resistance among antiretroviral-naive persons in the HIV Outpatient Study, 1999-2011
    Kate Buchacz
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Antimicrob Chemother 70:2337-46. 2015
  4. pmc Trends in Decline of Antiretroviral Resistance among ARV-Experienced Patients in the HIV Outpatient Study: 1999-2008
    Kate Buchacz
    Divisions of HIV AIDS Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, Mail Stop E45, Atlanta, GA 30333, USA
    AIDS Res Treat 2012:230290. 2012
  5. pmc CD4 Cell Counts at HIV Diagnosis among HIV Outpatient Study Participants, 2000-2009
    Kate Buchacz
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    AIDS Res Treat 2012:869841. 2012
  6. doi request reprint Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US
    Kate Buchacz
    Divisions of HIV AIDS Prevention, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Antivir Ther 18:65-75. 2013
  7. doi request reprint AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study
    Kate Buchacz
    Divisions of HIV AIDS Prevention, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS 24:1549-59. 2010
  8. ncbi request reprint Early markers of HIV-1 disease progression in a prospective cohort of seroconverters in Bangkok, Thailand: implications for vaccine trials
    Kate Buchacz
    Epidemic Intelligence Service, Division of Applied Public Health Training, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 36:853-60. 2004
  9. doi request reprint Changes in the use of HIV antiretroviral resistance testing in a large cohort of U.S. patients, 1999 to 2006
    Kate Buchacz
    Divisions of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 53:625-32. 2010
  10. doi request reprint Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005
    Kate Buchacz
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS 22:1345-54. 2008

Detail Information

Publications15

  1. ncbi request reprint Changing Clinician Practices and Attitudes Regarding the Use of Antiretroviral Therapy for HIV Treatment and Prevention: Results from the HPTN 065 Study
    Kate Buchacz
    Division of HIV AIDS Prevention, US Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Int Assoc Provid AIDS Care . 2016
    ..In line with changing HIV treatment guidelines during 2010 to 2013, clinicians increasingly supported early ART for treatment and prevention...
  2. ncbi request reprint Changes in the clinical epidemiology of HIV infection in the United States: implications for the clinician
    Kate Buchacz
    Centers for Disease Control and Prevention, 1600 Clifton Road Northeast, Mailstop E 45, Atlanta, GA 30333, USA
    Curr Infect Dis Rep 11:75-83. 2009
    ..Providers should ensure patients undertake preventive lifestyle changes (eg, smoking cessation, exercise, weight loss, dietary modification) and undergo recommended screening tests to reduce their risk for these important comorbidities...
  3. doi request reprint Trends in use of genotypic resistance testing and frequency of major drug resistance among antiretroviral-naive persons in the HIV Outpatient Study, 1999-2011
    Kate Buchacz
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Antimicrob Chemother 70:2337-46. 2015
    ..Monitoring antiretroviral drug resistance can inform treatment recommendations; however, there are few such data from US patients before they initiate ART...
  4. pmc Trends in Decline of Antiretroviral Resistance among ARV-Experienced Patients in the HIV Outpatient Study: 1999-2008
    Kate Buchacz
    Divisions of HIV AIDS Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, Mail Stop E45, Atlanta, GA 30333, USA
    AIDS Res Treat 2012:230290. 2012
    ..Resistance to PIs among PI-exposed patients decreased, possibly due to increased representation of patients whose only PI exposures were to boosted PIs...
  5. pmc CD4 Cell Counts at HIV Diagnosis among HIV Outpatient Study Participants, 2000-2009
    Kate Buchacz
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    AIDS Res Treat 2012:869841. 2012
    ..Conclusions. There is need for routine universal HIV testing to reduce the frequency of late HIV diagnosis and increase opportunity for patient- and potentially population-level benefits associated with early antiretroviral treatment...
  6. doi request reprint Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US
    Kate Buchacz
    Divisions of HIV AIDS Prevention, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Antivir Ther 18:65-75. 2013
    ....
  7. doi request reprint AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study
    Kate Buchacz
    Divisions of HIV AIDS Prevention, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS 24:1549-59. 2010
    ..To assess the incidence and spectrum of AIDS-defining opportunistic illnesses in the highly active antiretroviral therapy (cART) era...
  8. ncbi request reprint Early markers of HIV-1 disease progression in a prospective cohort of seroconverters in Bangkok, Thailand: implications for vaccine trials
    Kate Buchacz
    Epidemic Intelligence Service, Division of Applied Public Health Training, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 36:853-60. 2004
    ..We examined pretreatment HIV-1 viral loads and CD4 cell counts in recent HIV-1 seroconverters to inform selection of these endpoints...
  9. doi request reprint Changes in the use of HIV antiretroviral resistance testing in a large cohort of U.S. patients, 1999 to 2006
    Kate Buchacz
    Divisions of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 53:625-32. 2010
    ....
  10. doi request reprint Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005
    Kate Buchacz
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS 22:1345-54. 2008
    ..To assess temporal trends in the rates of hospitalizations and associated diagnoses among HIV-infected patients before and during the era of highly active antiretroviral therapy...
  11. ncbi request reprint HIV incidence among men diagnosed with early syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005
    Kate Buchacz
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Acquir Immune Defic Syndr 47:234-40. 2008
    ..We sought to estimate HIV incidence among men diagnosed with primary or secondary (P&S) syphilis in sexually transmitted disease (STD) clinics in Atlanta, San Francisco, and Los Angeles...
  12. ncbi request reprint Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy
    K Buchacz
    Division of HIV AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    HIV Med 7:451-6. 2006
    ..We assessed the incidence of grade 2 and higher hypophosphataemia in the HIV Outpatient Study (HOPS)...
  13. ncbi request reprint Syphilis epidemics and human immunodeficiency virus (HIV) incidence among men who have sex with men in the United States: implications for HIV prevention
    Kate Buchacz
    Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Sex Transm Dis 32:S73-9. 2005
    ..Comprehensive and integrated HIV/STD prevention and control efforts are also needed to halt the spread of syphilis and reduce HIV transmission among gay and bisexual men...
  14. doi request reprint Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996-2007
    P R Spradling
    Division of Viral Hepatitis, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA
    J Viral Hepat 17:879-86. 2010
    ....
  15. doi request reprint Treatment of hepatitis C virus (HCV) infection in patients coinfected with HIV in the HIV Outpatient Study (HOPS), 1999-2007
    C Vellozzi
    Division of HIV AIDS Prevention, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Viral Hepat 18:316-24. 2011
    ..Treatment of HCV infection in patients coinfected with HCV/HIV should be considered a priority, given the increased risk of accelerated end-stage liver disease...